Actuate Therapeutics Makes Public Debut
August 18, 2024 at 13:40 PM EDT
Actuate Therapeutics opened on Aug. 13 at $9.88. The biopharmaceutical company had priced its initial public offering of 2.8 million shares at a price of $8.00 per share.
